| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/20/1997 | CA2205056A1 Method for reducing the severity of gastro-intestinal damage |
| 03/19/1997 | EP0763204A1 Detection of different hiv genotypes utilizing a synthetic peptide-modified immunoassay |
| 03/19/1997 | EP0763131A1 Toxin assay |
| 03/19/1997 | EP0763062A1 New opioid peptide analogs with mixed mu agonist/delta antagonist properties |
| 03/19/1997 | EP0763051A1 3'-(4'-) nonradioactively tagged nucleosides and nucleotides with aminocarboxylic acid, peptide or carboxylic acid spacer |
| 03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/19/1997 | EP0754302A4 Methods and apparatus for synthesizing labeled combinatorial chemical libraries |
| 03/19/1997 | CN1145640A Method for detection of methylthioadenosine phosphorylase deficiency in mammalian cells |
| 03/19/1997 | CN1145589A Method for antigen-specific immunoregulation by T-Cell alpha chain |
| 03/19/1997 | CN1145369A Peptide useful as ligand |
| 03/18/1997 | US5612453 Viricides |
| 03/18/1997 | US5612314 Nitrosylated neuropeptides |
| 03/18/1997 | US5612311 Cyclic peptides |
| 03/18/1997 | US5612042 Vaccine against streptococcus suis infection |
| 03/18/1997 | US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers |
| 03/13/1997 | WO1997009429A2 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | WO1997009347A1 Cytolytic bradykinin antagonists |
| 03/13/1997 | WO1997009346A1 Des-arg9-bk antagonists |
| 03/13/1997 | WO1997009344A2 Librairies of backbone-cyclized peptidomimetics |
| 03/13/1997 | CA2230927A1 Compounds and methods for diagnosis of tuberculosis |
| 03/13/1997 | CA2230907A1 Cytolytic bradykinin antagonists |
| 03/13/1997 | CA2230861A1 Libraries of backbone-cyclized peptidomimetics |
| 03/12/1997 | EP0761684A2 Alanine substitution analogues of magainin peptides |
| 03/12/1997 | EP0761682A1 Cyclodepsipeptide |
| 03/12/1997 | EP0760678A1 Quantitation of individual protein kinase activity |
| 03/12/1997 | EP0588873B1 Treatment of liver cancer |
| 03/12/1997 | EP0583338B1 Method for synthesizing peptides, novel amino acid derivatives used therein, and methods for preparing same |
| 03/12/1997 | EP0378671B1 Insulinomimetic and insulin receptor binding site peptides |
| 03/12/1997 | CN1145032A Monoclonal anbibodies which bind to tumor rejection antigen precursor MAGE-1, recombinant MAGE-1, and MAGE-1 derived immunogenic peptides |
| 03/11/1997 | US5610279 Human TNF receptor |
| 03/11/1997 | US5610271 Kappa receptor selective opioid peptides |
| 03/11/1997 | US5610145 Carbamate stereoisomers |
| 03/11/1997 | US5610142 Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids |
| 03/11/1997 | US5610141 Cell division stimulant |
| 03/11/1997 | US5610140 Bradykinin receptor antagonists with neurokinin receptor blocking activity |
| 03/11/1997 | US5610047 Trehalose |
| 03/11/1997 | US5610031 B1k chain of laminin and methods of use |
| 03/11/1997 | US5609870 Antisecretory, immunology |
| 03/06/1997 | WO1997008304A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
| 03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | WO1997008198A1 Antigenic peptide compounds and immunoassay method |
| 03/06/1997 | WO1997002344A3 Vaccine for infectious agents, composition for treating and preventing hiv infections |
| 03/06/1997 | WO1996040768A3 Anti-fungal and anti-bacterial histatin-based peptides |
| 03/06/1997 | CA2230160A1 Antimicrobial cationic peptides and methods of screening for the same |
| 03/05/1997 | EP0760376A1 Peptides inhibiting phospholipase c |
| 03/05/1997 | EP0759941A1 Heterodimer polypeptide immunogen carrier composition and method |
| 03/05/1997 | EP0759937A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 03/05/1997 | EP0759934A1 Neurotensin antagonist peptides |
| 03/05/1997 | EP0759933A1 Beta sheet forming peptides and gels made thereof |
| 03/05/1997 | EP0759786A1 Somatostatin binding peptide-metal chelate conjugates |
| 03/05/1997 | EP0759772A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 03/05/1997 | EP0759771A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 03/05/1997 | EP0759770A1 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 03/05/1997 | EP0759769A1 Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (elam-1) |
| 03/05/1997 | EP0585300B1 Galanin antagonist |
| 03/05/1997 | EP0584360B1 Wf11243 substance |
| 03/05/1997 | EP0564466B1 Lhrh-antagonists |
| 03/05/1997 | EP0504207B1 Peptide derivative, process for the preparation thereof, pharmaceutical preparation containing it |
| 03/04/1997 | USH1638 Cyclic hexapeptide |
| 03/04/1997 | US5607914 Polypeptides for fungicides on plants |
| 03/04/1997 | US5607862 Assay for N-terminal type I collagen telopeptide that survives bone resorption in vivo |
| 03/04/1997 | US5607858 Pentapeptides or hexapeptide amides for diagnosis and anticoagulants |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 02/27/1997 | WO1997007208A1 Nucleic acid molecules encoding peptides having pronociceptive properties |
| 02/27/1997 | WO1997007132A1 Epitope tagging system |
| 02/27/1997 | WO1997007131A1 Acylated oligopeptides containing phosphotyrosine as inhibitors of protein tyrosine kinases |
| 02/27/1997 | WO1997006828A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997006821A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | WO1997006696A1 Improved proteinaceous animal chew with dentally therapeutic cation |
| 02/27/1997 | WO1997006685A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | WO1997004005A3 Cyclosporin derivatives with anti-hiv effect |
| 02/27/1997 | CA2229595A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 02/27/1997 | CA2229543A1 Heat shock protein-based vaccines and immunotherapies |
| 02/27/1997 | CA2229540A1 Epitope tagging system |
| 02/26/1997 | EP0759036A1 Immunointeractive molecules-i |
| 02/26/1997 | EP0759032A1 Isolated, mage-3 derived peptides which complex with hla-a2 molecules and uses thereof |
| 02/26/1997 | EP0702558A4 Novel opioid peptide inhibitors |
| 02/26/1997 | EP0635025A4 Process for preparing modified proteins. |
| 02/26/1997 | EP0519976B1 Neutrophil stimulating peptides |
| 02/25/1997 | US5605809 Reagents comprising characteristically folded peptide backbone each end of which is conjugated to a fluorophore |
| 02/20/1997 | WO1996040757A3 Lhrh antagonist peptides |
| 02/20/1997 | WO1996031531A3 Fluorescent peptides |
| 02/19/1997 | EP0758342A1 New peptide active substance and production thereof |
| 02/19/1997 | EP0758341A1 FACTOR Xa INHIBITORS |
| 02/19/1997 | EP0758339A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/18/1997 | US5604203 Analogs of peptide YY and uses thereof |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604092 Method for the detection of HIV-1 using a cyclosporine-specific monoclonal antibody that reacts with the P24 Gag protein |
| 02/18/1997 | US5603951 Cyclosporin-containing soft capsule compositions |
| 02/13/1997 | WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997005163A1 Cyclic peptide anti-fungal agents |
| 02/13/1997 | WO1997005162A1 Process for producing dolastatin 15 and intermediates thereof |
| 02/13/1997 | WO1997005096A1 PROCESS FOR PRODUCING α-(N,N DIALKYL)-AMINO CARBOXYLIC ACID AMIDES |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004741A1 Preparation used in dental care |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/13/1997 | WO1996002572A3 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |